Drug recall · December 9, 2020
ARIPIPRAZOLE TABLETS recall
Why: FAILED DISSOLUTION SPECIFICATIONS: Possibility of out-of-specification (OOS) dissolution limits for the remaining shelf life of the Aripiprazole Tablets
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
ARIPIPRAZOLE TABLETS, 15 mg, 30-count. bottles, Rx Only, GSMS Incorporated, Manufactured by: Apotex Inc. Toronto, Ontario, Canada, Packaged by GSMS, Incorporated, Camarillo, CA 93012 USA, NDC #60429-449-30
- Lots / codes
Lot #: GS026353, GS027150, GS027653, GS028044, Exp. Date: 02/2021
- Quantity
- 11,922 bottles
- Company
- Golden State Medical Supply Inc., Camarillo, CA
- Distribution
- Distributed Nationwide in the USA
- Initiated
- November 17, 2020 · Voluntary: Firm initiated
- Classified
- November 30, 2020
- Reported
- December 9, 2020
- Ended
- July 22, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Aripiprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.